The Recombinant Saccharomyces cerevisiae UPF0479 membrane protein YPR204C-A (YPR204C-A) is a recombinant protein derived from the yeast Saccharomyces cerevisiae. This protein is part of the UPF0479 family, which is known for its involvement in various cellular processes, although specific functions of YPR204C-A remain largely uncharacterized. The recombinant form of this protein is often used in life sciences research to study its biochemical functions and interactions.
While specific biochemical functions of YPR204C-A are not well-documented, proteins within the UPF0479 family are generally involved in various cellular processes. YPR204C-A is believed to participate in several pathways, although detailed information on these pathways is limited. It is known to interact with other proteins, which can be crucial for understanding its role in cellular processes .
Recombinant YPR204C-A is used in research to study its structure, function, and interactions. The availability of this protein facilitates investigations into its potential roles in cellular processes, which can contribute to understanding broader biological mechanisms.
For functional and structural characterization, large quantities of high-purity YPR204C-A are required. Efficient purification protocols, often involving chromatography techniques, are essential for maintaining native protein activity and structure .
Further studies are needed to fully understand the biochemical functions and pathways in which YPR204C-A is involved. Utilizing S. cerevisiae as an expression system could provide insights into its post-translational modifications and interactions, potentially revealing its functional significance in yeast and other organisms.
References:
KEGG: sce:YER190C-B
UPF0479 membrane protein YPR204C-A is a protein encoded by the YPR204C-A gene in Saccharomyces cerevisiae (Baker's yeast), specifically strain ATCC 204508/S288c . This protein belongs to the UPF0479 family of uncharacterized proteins, with "UPF" designating "uncharacterized protein family." The protein consists of 160 amino acid residues and is localized to cellular membranes. Its significance in research stems from its potential as a model for studying membrane protein integration, trafficking, and function in eukaryotic systems. The protein is relatively small compared to many membrane proteins, making it potentially valuable for structural studies and investigations into fundamental aspects of membrane protein biology in yeast, which serves as an important eukaryotic model organism.
When using E. coli for YPR204C-A expression, consider these methodological approaches:
Specialized E. coli strains: Use strains like BL21(DE3)pLysS or C41/C43(DE3) that are engineered for membrane protein expression
Fusion partners: Employ solubility-enhancing tags such as MBP, SUMO, or Thioredoxin
Codon optimization: Adapt the sequence for E. coli codon usage to enhance translation efficiency
For higher fidelity expression:
Yeast systems: Pichia pastoris or native S. cerevisiae offer proper eukaryotic folding machinery
Insect cell systems: Baculovirus-mediated expression provides advanced eukaryotic processing
The choice should be guided by research objectives - E. coli for high yield and initial characterization, yeast or insect cells for functional studies requiring proper folding and post-translational modifications.
For optimal stability of recombinant YPR204C-A, the protein should be stored at -20°C for routine use, and at -80°C for extended storage periods . The recommended storage buffer consists of a Tris-based buffer supplemented with 50% glycerol, which has been optimized specifically for this protein . This high glycerol concentration prevents ice crystal formation and maintains protein conformational stability during freeze-thaw cycles.
For working with the protein, it's advisable to prepare small aliquots to minimize freeze-thaw cycles, as repeated freezing and thawing can lead to protein denaturation and loss of function. Working aliquots can be stored at 4°C for up to one week . When handling membrane proteins like YPR204C-A, the following additional considerations are important:
Maintain a suitable detergent concentration above the critical micelle concentration (CMC) to prevent protein aggregation
Include protease inhibitors to prevent degradation
Consider adding reducing agents like DTT or β-mercaptoethanol if the protein contains cysteine residues
Document protein concentration, buffer composition, and preparation date on each aliquot
These precautions will help ensure maximum retention of protein structure and function for experimental applications.
Optimizing soluble expression of membrane proteins like YPR204C-A requires systematic evaluation of multiple variables through factorial experimental design. Based on established recombinant protein expression strategies, the following multivariate approach is recommended:
| Variable | Low Level | Mid Level | High Level | Significance* |
|---|---|---|---|---|
| Induction OD600 | 0.6 | 0.8 | 1.0 | High (p<0.0001) |
| IPTG concentration (mM) | 0.1 | 0.5 | 1.0 | Medium (p=0.0387) |
| Expression temperature (°C) | 16 | 25 | 37 | High (p<0.0001) |
| Yeast extract (g/L) | 5 | 10 | 15 | High (p=0.0004) |
| Tryptone (g/L) | 5 | 10 | 15 | High (p=0.0027) |
| Glucose (g/L) | 0 | 1 | 2 | Medium (p=0.0920) |
| Kanamycin (μg/mL) | 30 | 50 | 70 | Low (p>0.1) |
*Significance levels based on similar membrane protein studies
Implement a fractional factorial design (2^8-4) with center point replicates to evaluate these variables simultaneously while minimizing experiment numbers . For YPR204C-A, focus particularly on:
Lower induction temperatures (16-25°C): These typically enhance membrane protein folding by slowing synthesis rate
Post-induction time: Limit to 4-6 hours to prevent formation of inclusion bodies
Solubilization agents: Consider adding 0.5-1.0% glycerol or low concentrations of mild detergents
This systematic approach allows identification of statistically significant factors affecting YPR204C-A expression, enabling development of an optimized protocol that maximizes soluble protein yield while maintaining protein functionality .
Enhancing membrane insertion efficiency of YPR204C-A requires addressing the inherent challenges of membrane protein biogenesis. Research on type III membrane proteins suggests that translocation efficiency can be significantly improved through strategic modifications to targeting and insertion mechanisms .
One evidence-based approach involves modifying the protein's topogenic signals. Similar to studies with the human β2-adrenergic receptor (another membrane protein), conversion from type IIIb to type IIIa membrane protein structure by introducing an N-terminal cleavable signal sequence can enhance translocation across the endoplasmic reticulum membrane . For YPR204C-A, consider the following methods:
Signal sequence engineering:
Introduce a well-characterized cleavable signal sequence (e.g., from Sec61α or prolactin) at the N-terminus
Optimize the hydrophobicity profile of transmembrane domains
Design constructs with modified N-terminal charge distribution
Co-expression with membrane insertion facilitators:
Express with chaperones that assist membrane protein folding (e.g., DnaK/DnaJ/GrpE system)
Co-express components of the translocon complex
Include proteins that modify membrane lipid composition
Systematic evaluation of expression conditions:
| Parameter | Range to Test | Evaluation Method |
|---|---|---|
| Membrane-mimetic additives | 0.5-5% glycerol | Western blot of membrane fractions |
| Expression temperature | 16-30°C | Functional assays |
| Induction rate | 0.01-0.5 mM IPTG | Membrane:cytosol ratio quantification |
| Media supplements | Various lipids | Fluorescence-based localization |
These modifications can significantly enhance the translocation efficiency of YPR204C-A, resulting in higher yields of properly folded and functionally inserted membrane protein .
Purifying membrane proteins while maintaining their native structure requires specialized approaches. For YPR204C-A, a multi-step purification strategy is recommended:
Harvest cells and disrupt by sonication or mechanical methods in buffer containing protease inhibitors
Isolate membrane fraction through differential centrifugation (40,000-100,000 × g)
Solubilize membranes using detergents optimized for YPR204C-A:
| Detergent Class | Examples | Working Concentration | Advantages |
|---|---|---|---|
| Mild non-ionic | DDM, LMNG | 1-2× CMC | Maintains protein-protein interactions |
| Zwitterionic | CHAPS, Fos-choline | 3-5× CMC | Effective solubilization, moderate harshness |
| Amphipols | A8-35, PMAL-C8 | 1:5 (protein:amphipol) | Stabilizes protein after purification |
Stage 2: Chromatographic Purification
Implement a sequential purification scheme:
IMAC (Immobilized Metal Affinity Chromatography): Using the recombinant protein's affinity tag
Size-exclusion chromatography: To separate monomeric protein from aggregates
Ion-exchange chromatography: For polishing and removing contaminants
Stage 3: Functional Validation
Assess protein quality at each purification step using:
SDS-PAGE and Western blotting for purity assessment
Circular dichroism to confirm secondary structure
Thermal shift assays to evaluate stability
Reconstitution into liposomes for functional tests
For structural biology applications, consider detergent exchange to more crystallization-friendly options like OG or DM during the final purification steps. This systematic approach typically yields protein with >90% purity while preserving the native folding necessary for functional studies.
Expression systems significantly impact the folding and functional properties of membrane proteins like YPR204C-A due to differences in membrane composition, folding machinery, and post-translational modification capabilities. A comparative analysis reveals system-specific effects:
To evaluate the impact of expression system on YPR204C-A function:
Compare lipid binding properties across systems using fluorescence-based assays
Assess thermal stability differences using differential scanning calorimetry
Measure functional parameters in reconstituted systems using liposome-based assays
These comparisons can guide selection of the most appropriate expression system based on specific research objectives.
Comprehensive structural characterization of YPR204C-A requires a multi-technique approach addressing different levels of structural organization. The following methodologies provide complementary insights:
Mass spectrometry (MS) with techniques like MALDI-TOF for accurate mass determination
MS/MS peptide mapping for sequence verification and post-translational modification identification
Circular Dichroism (CD) spectroscopy to quantify α-helical content expected in transmembrane domains
Fourier-Transform Infrared Spectroscopy (FTIR) for complementary secondary structure information
| Technique | Resolution | Sample Requirements | Key Advantages | Limitations |
|---|---|---|---|---|
| X-ray Crystallography | 1.5-3.5 Å | 5-10 mg crystallized protein | Atomic resolution | Challenging crystallization |
| Cryo-EM | 2.5-4 Å | 1-2 mg purified protein | Native environment possible | Size limitations |
| NMR Spectroscopy | Atomic level | 5-15 mg isotope-labeled protein | Dynamic information | Size constraints |
| SAXS | 10-30 Å | 1-2 mg in solution | Low concentration needs | Low resolution |
Limited proteolysis combined with MS to identify exposed regions
Site-directed fluorescence labeling to map membrane-embedded domains
Cysteine accessibility methods to determine transmembrane segment orientation
For YPR204C-A specifically, its relatively small size (160 amino acids) makes it amenable to solution NMR studies if sufficient quantities of isotope-labeled protein can be produced. Alternatively, recent advances in cryo-EM for smaller membrane proteins using specialized approaches like embedding in nanodiscs or amphipols could provide structural insights without crystallization challenges.
Site-directed mutagenesis provides powerful insights into structure-function relationships of membrane proteins like YPR204C-A. A systematic mutagenesis approach should target specific domains and conserved residues:
Transmembrane domain mutations: Replace key hydrophobic residues to assess membrane anchoring
Charged residue substitutions: Modify charged amino acids that may participate in electrostatic interactions
Conserved motif alterations: Target any sequence patterns conserved across the UPF0479 family
| Region | Target Residues | Mutation Type | Rationale | Expected Effect |
|---|---|---|---|---|
| N-terminus | M1, M2 | M→A | Test alternate translation start | Expression level changes |
| Hydrophobic regions | L, I, V clusters | L/I/V→A | Disrupt membrane insertion | Altered localization |
| Basic patches | K3, K15, R23, R35 | K/R→Q | Neutralize positive charges | Modified membrane topology |
| Aromatic residues | F28, F31, F41, Y45 | F/Y→A | Eliminate aromatic interactions | Structural destabilization |
| C-terminus | S158, H159, S160 | S/H→A | Test C-terminal role | Function modification |
Generate mutations using overlap extension PCR or commercial site-directed mutagenesis kits
Express wild-type and mutant proteins under identical conditions
Compare expression levels, membrane integration, and stability
Conduct functional assays to determine impact on biological activity
For validation, combine mutagenesis with crosslinking studies using photoactivatable amino acid analogs incorporated at specific positions. This approach can map interaction surfaces and identify critical residues for protein-protein or protein-lipid interactions, providing mechanistic insights into YPR204C-A function within the membrane environment.
Scaling up YPR204C-A production for structural studies requires systematic optimization of both upstream and downstream processes. Based on recombinant protein expression principles, the following approach is recommended:
Bioreactor cultivation: Transition from shake flasks to controlled bioreactors (5-30L)
Feed strategy development: Implement fed-batch cultivation with optimized carbon source feeding
Induction optimization: Fine-tune induction parameters based on earlier factorial design results
| Parameter | Optimization Range | Monitoring Method | Target Value |
|---|---|---|---|
| Dissolved oxygen | 20-50% | Online probe | ≥30% |
| pH | 6.5-7.5 | Online probe | 7.0±0.2 |
| Feed rate | 0.1-0.5 g glucose/L/h | Calculated | Based on μmax |
| Agitation | 200-800 rpm | Fixed or cascade | Maintain DO |
| Induction temperature | 16-30°C | Temperature control | 25°C |
| Induction OD600 | 5-30 | Online OD or sampling | 15-20 |
Cell disruption scale-up: Transition from sonication to high-pressure homogenization
Membrane preparation: Implement tangential flow filtration for membrane isolation
Chromatography scale-up: Increase column dimensions while maintaining bed height:diameter ratios
Detergent optimization: Balance between solubilization efficiency and downstream processing compatibility
Scale-up typically introduces challenges including:
Oxygen transfer limitations affecting cell growth
Heat transfer issues affecting protein folding
Mixing inefficiencies leading to concentration gradients
Increased mechanical stress potentially damaging membrane integrity
For structural biology applications, prioritize protein quality over quantity, as heterogeneous preparations severely impact crystallization success or cryo-EM data quality. Implement rigorous quality control at each step using analytical SEC, multi-angle light scattering, and functional assays to ensure consistency between batches.
Investigating YPR204C-A interactions with lipids and other proteins requires sophisticated biophysical approaches that can probe these associations under near-native conditions. The following methodologies are particularly informative:
Microscale Thermophoresis (MST): Measures binding affinities between YPR204C-A and fluorescently labeled lipids in solution, requiring minimal protein amounts (≤1 μg).
Surface Plasmon Resonance (SPR): Provides real-time kinetic data for YPR204C-A interaction with immobilized lipid bilayers.
Hydrogen-Deuterium Exchange Mass Spectrometry (HDX-MS): Maps regions of YPR204C-A that become protected upon lipid binding, indicating interaction interfaces.
| Membrane Mimetic | Advantages | Limitations | Suitable Techniques |
|---|---|---|---|
| Nanodiscs | Native-like bilayer, defined size | Complex preparation | NMR, cryo-EM, HDX-MS |
| Liposomes | Closest to native membrane | Heterogeneity | Functional assays, SPR |
| Bicelles | Compatibility with NMR | Limited stability | Solution NMR, CD |
| Amphipols | High stability | Non-native environment | cryo-EM, SAXS |
Chemical Cross-linking coupled with MS: Identifies interaction partners and maps binding interfaces by covalently linking proximal proteins before MS analysis.
FRET-based approaches: When combined with strategic fluorophore placement, can reveal dynamic interactions and conformational changes upon binding.
Co-immunoprecipitation with quantitative proteomics: Identifies the interactome of YPR204C-A under different cellular conditions.
For comprehensive characterization, integrate multiple techniques to build a complete picture of YPR204C-A's interaction network. For example, initial screening using pull-down assays can identify potential interaction partners, followed by biophysical validation using SPR or isothermal titration calorimetry, and structural characterization of complexes using cryo-EM or X-ray crystallography.